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Abstract The post-translationally modified peptide antibiotic 
nisin has been cleaved by a number of proteases and the 
fragments produced purified, characterised chemically, and 
assayed for activity in inhibiting the growth of Lactococcus 
lactis MG1614 and Micrococcus luteus NCDO8166. These 
results provide information on the importance of different parts 
of the nisin molecule for its growth-inhibition activity. Removal 
of the C-terminal five residues leads to approximately a 10-fold 
decrease in potency, while removal of a further nine residues, 
encompassing two of the lanthionine rings, leads to a 100-fold 
decrease. There are some differences between analogous frag- 
ments of nisin and subtilin, suggesting possible subtle differences 
in mode of action. Cleavage within, or removal of, lanthionine 
ring C essentially abolishes the activity of nisin. The fragment 
ulsin t-12 is inactive itself, and specifically antagonises the 
growth-inhibitory action of nisin. These results are discussed in 
lerms of current models for the mechanism of action of nisin. 
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mation of voltage-dependent pores in biological membranes 
[8-10], although recent evidence indicates that the inhibition 
of the outgrowth of spores by nisin and subtilin takes place by 
a different mechanism [11,12]. We have been studying the 
structure-activity relationships in nisin and subtilin, by both 
genetic and chemical modification of the structure [12-20], 
with a view to understanding their mechanism of action and 
to developing new derivatives with desirable properties. We 
now report the preparation, characterisation and anti-bacter- 
ial activity of a number of proteolytic fragments of nisin and 
subtilin, which allow us to define the parts of the molecule 
most important for biological activity. 
2. Materials and methods 
Nisin and subtilin were prepared as previously described [14,15]; 
[Ser33]-nisin, in which the serine residue at position 33 has escaped 
processing to a dehydroalanine r sidue, was isolated as a minor com- 
ponent of commercial nisin. All proteases were obtained from Sigma 
Chemical Co., Poole, Dorset, UK. 
~. Introduction 
The post-translationally modified peptide antibiotics known 
:ts 'lantibiotics' contain cyclic structures formed by lanthio- 
aine or 3-methyl-lanthionine r sidues, and often also dehy- 
droalanine and/or dehydrobutyrine r sidues [1]. The first lan- 
!ibiotic to be characterised was nisin, produced by strains of 
Lactococcus lactis carrying a transposon containing genes 
coding for the nisin precursor and for proteins involved in 
aisin biosynthesis and resistance [2-5]. Nisin has been quite 
videly used as a food preservative, notably in cheese and 
,~ther dairy products and in canned vegetables, for some 30 
.,ears [6,7]. It inhibits the growth of a wide range of Gram- 
~ositive organisms, and also inhibits the germination and/or 
mtgrowth of  spores of  Bacillus and Clostridium species [6]. 
Fhe growth-inhibitory activity of nisin, and that of other 'type 
V lantibiotics uch as subtilin, appears to be due to the for- 
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~)Abbreviations used for post-translationally modified residues are 
defined in the caption to Fig. 1. 
2.1. Production and purification of nisin and subtilin fragments 
The sites of cleavage of nisin by the proteases used are indicated in 
Fig. 1. The procedures used for each proteolytic digestion were as 
follows: in each case, the progress of the reaction was followed by 
HPLC of aliquots. Trypsin: 10 mg nisin was dissolved in 10 ml buffer 
(25 mM sodium acetate, 5 mM Tris acetate, 5 mM CaC12, pH 7.0), 
1 mg trypsin was added and the reaction mixture stirred at 30°C. 
Further aliquots of 0.5 mg trypsin were added after 24 and 48 h. 
After 3-4 days, the mixture was acidified and lyophilised. Subtilin 1-19 
and subtilin 3-29 were prepared by digestion of subtilin with trypsin in 
a similar way. Chymotrypsin: 5 mg nisin was dissolved in 5 ml buffer 
(25 mM Tris acetate, pH 7.5), 0.6 mg ct-chymotrypsin was added and 
the reaction mixture incubated at 30°C; a further 0.3 mg chymotryp- 
sin was added after 24 h. After 72 h, the reaction was stopped by 
acidification and lyophilisation. Thermolysin: 4 mg nisin was dissolved 
in 5 ml buffer (25 mM Tris acetate, 5 mM CaC12, pH 7.8), 0.8 mg 
thermolysin added, the mixture incubated at 35°C for 8 h and then 
acidified and lyophilised. This provided nisin 1 29; for more extensive 
thermolysin digestion to obtain additional cleavage in ring C, the 
incubation at 35°C was extended to 24 h; at this time, an additional 
0.5 mg thermolysin was added, and the reaction mixture left at room 
temperature for an additional 60 h before acidification and lyophilisa- 
tion. Nisin 1 29 was also obtained by exhaustive digestion of [SeraZ] - 
nisin with carboxypeptidase Y for 4-5 h at 30°C. 
The desired fragments were purified from the acidified and lyophi- 
lised reaction mixtures by reversed phase HPLC. In most cases, a 
Kromasil KR100-5C8 (250× 8 mm) column was used, but for purifi- 
cation of nisin M2 a Hypersil Pep C18 column was used. Elution was 
with a linear gradient from 0.06% aqueous trifluoroacetic acid to 
0.06% trifluoroacetic acid in 90% acetonitrile, 10% water. 
Nisin ~-31 was isolated as a minor component from a fermentation 
producing the mutant Dha33--*Ala nisin O) (Dodd, Horn, Chan, 
Clark, Gasson, Bycroft and Roberts, unpublished work). Nisin 1-a2 
and [des-Dha'5]-nisin 1 32 were prepared as previously described [13]. 
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2.2. Character&ation f n&& and subtilin fragments 
Each of the fragments was checked for purity by analytical HPLC 
and structurally characterised by amino acid analysis and plasma 
desorption mass spectrometry (Bioion 20), and in some cases by 1H 
NMR spectroscopy (Bruker AM500); these methods are described 
elsewhere [12]. 
2.3. Assays of biological acitivity 
Assays of inhibition of growth of L. lact& MG1614 (a nisin-sensi- 
tive strain lacking the transposon carrying the nis operon [20]) and of 
M. luteus NCDO8166 were carried out either by agar diffusion or by 
following growth in suspension by measuring absorbance at 600 nm. 
The results of all assays are presented as the mean of duplicate x- 
periments which agreed to within less than 20%. To determine the 
effect of pre-incubation of cells with nisin 1 12 on the growth-inhibi- 
tory effect of nisin, two 0.4-ml samples of a culture of L. lactis 
MGI614 in GM17 broth were taken and the cells harvested. One 
sample was incubated in 1 ml GM17 broth containing 20 /.tg/ml 
nisin 1-I2 for 30 min, while the control sample was incubated for the 
same period in broth alone. Cells from both samples were harvested, 
washed three times with GMI7 broth, resuspended in broth and ali- 
quots used to determine growth (A600) in the presence of 0-150 ng/ml 
nisin. 
3. Results and discussion 
3.1. Production and characterisation of n&& fragments 
The structure of nisin [14,22] is shown in Fig. 1 ; it can be 
seen to contain five rings formed by lanthionine or methyl- 
lanthionine residues. Subtilin has exactly the same ring struc- 
ture, but has 12 amino acid substitutions relative to nisin, and 
two deletions in the C-terminal 'tail'. The five lanthionine 
rings constrain the conformation of the molecule [18,23,24] 
and, presumably primarily as a consequence of these con- 
straints, nisin and subtilin are generally resistant to attack 
by proteolytic enzymes. However, we have found that pro- 
longed exposure to trypsin, chymotrypsin or thermolysin, as 
described in Section 2, can lead to rather specific cleavages of 
the molecule, as shown in Fig. 1, and these can be used to 
prepare fragments of the molecule. 
Trypsin cleaves the LyslZ-DAbu lz bond of nisin to give the 
nisin 1-12 fragment. It is not known whether the Lys22-DAbu 23 
bond is also cleaved, since the other cleavage product(s) were 
not isolated; cleavage at LysZ2-DAbu 23 in the absence of 
cleavage at Lysl2-DAbu 13 does not occur to a significant ex- 
tent, since the nisin 1-22 fragment is not a major product. The 
only aromatic amino-acid residues in nisin are His 27 and 
His a ,  and chymotrypsin cleaves, slowly and somewhat unex- 
pectedly, at Asn 2°. Initial cleavage by thermolysin (0.2 mg 
enzyme/mg nisin for 8 h) is at Ser 29 ; more prolonged igestion 
Thermolysin 
Acid ~a l ~ 
Dha 5 / Trypsin 
AI ~eu / 
Ile / ~Leu  Gly Met 
I a [ /S~ ~[ [ C I 
Ile-Dhb- DAla - A a s --DAbu Alas-Lys - DAbu Gly 
~s/  \ n / ,2 \ / 
S Ala s 
Pro - -  GlY10 I 
Asn2o 
I 
Thermolysin, S Met~1 
CPDe~ CPD' / ~ I /  
/ / His--Alas D DAbu - -Lys [  
~ / E \ / Chymotrypsin 
Lys-Dha Val His-Ile-Ser-Ala s DAbu--Ala 
32 ~ "~s  / ~5 
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Fig. 1. Structure of nisin, indicating the points of cleavage which 
generate the fragments discussed in the text. Dehydroalanine and 
dehydrobutyrine residues are abbreviated Dha and Dhb, 
respectively. Meso-lanthionine and 13-methyl-lanthionine residues are 
indicated by DAla-S-Ala8 and DAbu-S-Alas respectively (where the 
amino-terminal moieties have the D configuration). For details of 
cleavage conditions, Section 2. CPDI: exhaustive cleavage by car- 
boxypeptidase Y of [SerZZ]-nisin. CPD2: cleavage, presumably by 
endogenous carboxypeptidases, of the Dha 33 ~ Ala mutant of nisin. 
leads to additional cleavages of the Alala-Leu 16 and then the 
Leu16-Met 17 bonds in ring C, with release of Leu 16. Nisin is 
particularly resistant o carboxypeptidase action, but this re- 
sistance can be decreased by alterations to the primary struc- 
ture near the C-terminus. Thus [Ser33]-nisin, in which the ser- 
ine residue at position 33 has escaped processing to a 
dehydroalanine r sidue, can be isolated as a minor component 
of commercial nisin, and digestion of this with carboxypepti- 
dase Y yields nisin 1-29. Similarly, nisin a-a was isolated as a 
minor component, presumably resulting from the action of 
endogenous carboxypeptidases, from a fermentation produ- 
cing the mutant (Dha 33~Ala)  nisin (Dodd, Horn, Chan, 
Clark, Gasson, Bycroft and Roberts, unpublished work). 
Each of the fragments produced by these digestions was rig- 
orously purified by HPLC and structurally characterised by 
amino acid analysis and plasma desorption mass spectrome- 
try; in each case the measured masses were in excellent agree- 
ment with those expected from the proposed structure (Table 
1). 
3.2. Growth-inhibitory activity of fragments of nisin 
The activities of the various fragments of nisin as inhibitors 
Table 1 
Inhibition of bacterial growth by nisin and its fragments 
Compound Molecular ion MIC (/.tg/ml) 
Calc. Found L. lactis MG1614 M. luteus NCDO8166 
Nisin 3355.12 3354.8 
[Ser33]-Nisin 3373.13 3373.6 
Nisin 1-32 amide ~ 3156.90 3157.0 
Nisin 1 31 3058.76 3060.9 
Nisin 1-29 2808.45 2808.0 
Nisin 1-2° 1881 .31 1881 .2 
[Ala15.OH, H.Leua6] Nisin 1 29 2826.46 2828.1 
[des-Leu16,Alaa~-OH, H-Met lz] Nisin 1-29 2713.30 2715.8 
Nisin 1-12 1151 .43 1151 .7 
[des-Dha 5]nisin 1-32 amide a 3174.89 nd 
0.08 0.07 
0.12 0.08 
0.04 0.05 
0.70 nd b 
1.28 0.79 
9.21 3.50 
> 400 ~ 100 
> 400 ~ 200 
> 200 16.5 
> 200 4.48 
aData from [2]. 
bNot determined. 
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of the growth of Lactococcus lactis and Micrococcus luteus are 
summarised in Table 1. These can most simply be discussed 
by considering the progressive removal of residues from the 
(',-terminus of the molecule. Acid treatment of nisin leads to 
hydrolysis at Dha a3, forming nisin x-a2 amide [13] whose ac- 
l~vity is very similar to that of nisin itself. The non-essential 
ature of Dha aa is further demonstrated by the essentially full 
; ctivity of [Sera3]-nisin (Table 1) and of the Dha 33 ~ Ala mu- 
l int  (Dodd, Horn, Chan, Clark, Gasson, Bycroft and Ro- 
berts, unpublished work). Further removal of Va132, in 
Jisin 1-31, leads to a significant (,-- 10-fold) decrease in activity 
',gainst L. lactis, suggesting either that this valine residue 
~mkes a significant contribution to activity, or that the pres- 
nce of a negative charge at this point in the molecule is 
~ nfavourable. Removal of His al and Ile 3° to give nisin 1 29, 
~tae shortest fragment which retains all the lanthionine rings, 
::ives a molecule with 7% the activity against L. lactis and 10% 
he activity against M. luteus of the intact nisin molecule, 
howing that the C-terminal 'tail' of nisin plays a significant, 
,ut far from dominant, role in its antibacterial ctivity. 
Removal of the linked rings D and E, in nisin 1-2°, produces 
further substantial drop in activity, by an overall factor of 
00 against L. lactis and 50 against M. luteus. The antibacter- 
al activity of nisin 1-2° is, however, still readily measurable. It 
only with cleavage in, or removal of, ring C that the mole- 
ule becomes essentially totally inactive. Thermolysin cleavage 
,f the AlalS-Leu 16 and subsequently the Leu16-Met 17 bonds in 
ing C of nisin 1 29 leads to complete loss of activity. Analo- 
:ous results have been reported by Kuipers et al. [25], who 
ntroduced a tryptic cleavage site into ring C by substituting 
vlet ~7 with lysine; the mutant retained 50% activity, but this 
vas decreased to ,-~ 1% on cleavage by trypsin. Complete 
emoval of ring C, in nisin I 12, similarly leads to essentially 
omplete loss of activity against L. lactis (Table 1). By con- 
rast, this fragment retains slight but significant activity 
Lgainst M. luteus, which is very sensitive to lantibiotic action. 
Fhe observation that nisin 1-12 is more active against his or- 
ganism than the 29-residue fragments in which ring C is pres- 
ent but cleaved ([Alal%OH, H-Leu 16] nisin I 29 and [des-Leu 16, 
kla15-OH, H-Met 17] nisin 1-29) is as yet unexplained. It may 
effect unfavourable interactions of the new charges in the 
atter molecules with a region of the nisin binding site (see 
)elow) which normally accommodates the hydrophobic ring 
An intact ring C is thus essential for antibacterial ctivity of 
fisin. Earlier evidence has shown that this is also true for ring 
k; acid hydrolysis at Dha 5 in nisin ~ a2 amide leads to loss of 
tctivity [13], but the Dha5Ala mutant retains full antibacterial 
tctivity [12], showing that it is the intact ring A, rather than 
he dehydro residue at position 5, which is required for this 
tctivity. The 'wedge' model for the formation by nisin of 
['able 2 
inhibition of bacterial growth by subtilin and its fragments 
2ompound MIC (gg/ml) 
L. lactis M. luteus 
MG1614 NCDO8166 
,;ubtilin 1.09 0.05 
Na-succinyl-Trp 1]subtilin ~ 21.3 0.34 
¢,ubtilin a- 29 49.3 34.5 
qubtilin 1-19 > 350 80.2 
Data from [5]. 
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Fig. 2. Effects of nisin 1 12 on the growth inhibitory effects of nisin 
and subtilin. Inhibition produced by 5 gg/ml nisin or 5 gg/ml subti- 
lin in an agar diffusion assay is set as 100%. The effects of nisin 1-12 
(e, []) and of [des Dha'5]-nisin 1 32 amide (©) on the inhibition of 
growth by these concentrations of nisin and subtilin are shown. 
transient pores in the bacterial membrane by induction of 
non-bilayer structures [10,26] postulates that the N-terminal 
part of nisin, comprising rings A-C, is responsible for binding 
of nisin to the membrane surface and/or its oligomerisation, 
while the more cationic C-terminal part of the molecule plays 
a role in pore formation. The present evidence is consistent 
with the idea that intact rings A and C are required for this 
binding function, and suggests that some pore formation is 
possible in the absence of the cationic C-terminal segment. 
3.3. Compar&on of the activity of nis& and subtilin fragments 
By comparison to nisin, subtilin has fewer potential sites for 
proteolytic leavage; Table 2 shows the growth-inhibitory ac- 
tivities of the two fragments we have been able to purify and 
characterise, subtilin a-z9 and subtilin 1-19. Nisin 1 20 and sub- 
tilin 1-19 each consist of rings A-C. As noted above, nisin 1-2° 
has 1% activity against L. lactis and 2% against M. luteus. The 
very similar fragment of subtilin, subtilin 1 a9, however, has 
significantly lower activity (<0.3% against L. lactis, and 
< 0.1% against M. luteus). It is possible that residue 20 has 
a crucial role in activity, although this residue is very different 
in the two molecules - Phe in subtilin and Asn in nisin. Alter- 
natively, this difference may reflect subtle differences in the 
mechanism of pore formation by these two lantibiotics. The 
data in Table 2 also suggest that the N-terminus of subtilin is 
important for its activity; both the natural derivative of sub- 
tilin which is succinylated on its N-terminus [16] and sub- 
tilin 3 29 show clear decreases in activity when compared to 
subtilin itself. 
3.4. Competitive antagonism of the antibacterial ction of nisin 
by nisin 1-12 
As noted above, nisin 1-12 almost completely lacks growth- 
inhibitory activity against L. lactis. We have found that it 
does, however, act as a specific antagonist of the growth-in- 
hibitory effects of nisin on this organism. Fig. 2 shows that 
incubation with increasing concentrations of nisin 1-~2 de- 
creases the size of the zone of inhibition produced by 5 gg/ 
ml nisin in an agar diffusion assay. 50% inhibition of the 
effects of this relatively high concentration of nisin 
(6×MIC) is achieved with 75 ~tg/ml nisin 1-12 (about a third 
132 
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Fig. 3. Effect of preincubation with nisin 1-12 on the growth-inhibi- 
tory effects of nisin on L. lactis MG1614. L. lactis cells were incu- 
bated with (11) or without (13) 20/.tg/ml nisin 1-12, and washed before 
the inhibition of growth by nisin was determined. 
of its own MIC). This is clearly a specific effect; as shown in 
Fig. 2, nisin 1-12 has no effect on growth inhibition by subtilin, 
and another inactive fragment of nisin, [des-Dha 5] nisin 1-32 
amide, does not antagonise the growth-inhibitory effects of 
nisin. The lack of effect on subtilin is interesting in that it 
provides support for the suggestion made above that there 
may be differences in the mechanism of action between isin 
and subtilin. The antagonism of or protection against the 
growth-inhibitory effects of nisin by nisin 1-12 is also seen 
when the cells are preincubated with nisin 1-12 and then 
washed before being challenged by nisin (Fig. 3); in this assay, 
20 ~tg/ml nisin 1-12 completely protects against the effects of 
150 ng/ml nisin. 
Bearing in mind the proposed mechanism of the antibacter- 
ial effect of nisin, involving the formation of pores in the cell 
membrane [10], several possible mechanisms of this antago- 
nistic action of nisin 1 12 can be envisaged. It is important o 
note first that, although we have shown that nisin 1-12 can 
induce nisin immunity [21], this can not be responsible for 
the antagonism described here, since the nisin-sensitive L. lac- 
tis strain MG1614 used for growth-inhibition assays lacks the 
transposon carrying the nis operon, including the genes con- 
ferring immunity (see [21]). The simplest explanation of the 
effects of nisin 1-12 is that it competes with nisin for some site 
which is essential for pore formation. The observation that 
nisin is able to form pores in protein-free liposomes [26] 
makes it unlikely that this essential site is a protein, but two 
other possibilities remain. First, nisin 1-12 could compete for a 
site on the cell membrane to which nisin must bind as a pre- 
liminary to pore formation - probably phosphatidyl glycerol 
[10,26]. Secondly, the competition could be at the level of the 
oligomerisation of nisin required for pore formation, if one 
postulates that an oligomer containing some nisin and some 
nisin 1-12 molecules is inactive. These two possibilities cannot 
be distinguished on the basis of the information presently 
available. The observation that nisin 1-12 does not antagonise 
the anti-bacterial ctivity of subtilin would imply either that 
subtilin binds to a different molecule in the membrane or that 
mixed nisin-subtilin oligomers cannot form. In either case, 
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there must be a clear discrimination i  binding between the 
two structurally similar lantibiotics. Although much remains 
to be learned of the mechanism of action of nisin and the 
mechanism of nisin immunity [21], the present results show 
that nisin 1-12 will be a valuable tool in these further investiga- 
tions. 
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